Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Bimekizumab effectively treated a man's chronic beard hair loss.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

A patient's grey hair regained color during treatment with adalimumab.

Adalimumab improved folliculitis decalvans in most patients.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Upadacitinib effectively treats psoriasis and lichen planus together.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Upadacitinib improved multiple immune-related conditions in one patient.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

The new delivery system could improve pain and inflammation relief in gout.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Efalizumab can cause unexpected excessive hair growth.